5/12/2023 0 Comments The Two Chambers by Pedro PuechMore than 90% of children reported improvement of hyperhidrosis at other sites. By their final office visit, more than 91% of the children with hyperhidrosis treated with oxybutynin experienced moderate or great improvement in their level of sweating and 94.9% experienced improvement in QOL. A self-assessment of hyperhidrosis was performed after 6 weeks and after the last consultation. Their quality of life (QOL) was evaluated using a validated clinical questionnaire before and after 6 weeks of pharmacologic therapy. A cohort of 97 patients was evaluated retrospectively, with particular attention to 59 children (ages 4–14 yrs) who were treated for longer than 6 months. We aimed to investigate the long-term effects of oxybutynin in treating children with palmar and plantar hyperhidrosis who had not undergone surgery and who were monitored for at least 6 months (median 19.6 mos). Oxybutynin for treating hyperhidrosis in children has been evaluated only in short-term studies.
0 Comments
Leave a Reply. |